Lemaitre Vascular (LMAT) FY2019 results: revenue $117 million, up 11.0% on the year
Lemaitre Vascular Inc. (LMAT) reported revenue of $117 million for fiscal 2019, the year ended 31 December 2019, up 11.0% on the year before. Net income was $18 million, down 21.8%, and diluted earnings per share $0.88. The figures are the company's own, from the 10-K it filed with the SEC on 12 March 2020.
Revenue
$117 million
+11.0% on the year
FY2012FY2019
Operating margin
18.1%
26.7% a year earlier
FY2012FY2019
Net income
$18 million
-21.8% on the year
FY2012FY2019
Diluted EPS
$0.88
-22.1% on the year
FY2012FY2019
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Revenue
117
106
101
+11.0%
Cost of revenue
37.4
31.6
30.2
+18.2%
Gross profit
79.9
73.9
70.7
+8.0%
Gross margin
68.1%
70.0%
70.1%
Research and development
9.3
8.2
6.6
+13.2%
Operating income
21.2
28.2
21.1
-24.9%
Operating margin
18.1%
26.7%
20.9%
Interest expense
0.0
0.0
0.0
Pre-tax income
21.7
28.4
21.1
-23.8%
Income tax
3.7
5.5
3.9
-31.9%
Effective tax rate
17.3%
19.3%
18.6%
Net income
17.9
22.9
17.2
-21.8%
Net margin
15.3%
21.7%
17.0%
Diluted EPS
$0.88
$1.13
$0.86
-22.1%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Operating cash flow
14.2
19.5
22.9
-27.3%
Capital expenditure
3.8
3.1
6.4
+23.1%
Free cash flow
10.4
16.5
16.5
-36.7%
Free cash flow margin
8.9%
15.6%
16.3%
Cash from investing
-24.1
-7.1
-29.0
Cash from financing
-4.6
-4.4
0.1
Depreciation and amortisation
5.4
4.3
4.1
+25.3%
Share-based compensation
2.6
2.3
2.3
+12.5%
Buybacks
0.7
0.7
0.8
-7.8%
Dividends paid
6.7
5.4
4.2
+23.7%
Dividend per share
$0.34
$0.28
$0.22
+21.4%
Diluted shares, weighted
20m
20m
20m
+0.4%
Balance sheet
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Shareholders' equity
148
130
110
+13.7%
Debt
0.0
0.0
0.0
Operating lease liabilities
14.0
n/a
n/a
Other liabilities
26.2
22.9
16.6
+14.8%
Total liabilities and equity
188
153
126
+23.0%
Fixed assets
14.9
14.1
12.4
+5.3%
Goodwill
40.0
29.9
23.8
+33.8%
Intangible assets
24.9
13.7
8.2
+81.8%
Investments
20.9
21.7
22.6
-3.6%
Cash and equivalents
11.8
26.3
19.1
-55.2%
Receivables
16.6
15.7
15.0
+5.4%
Other assets
59.4
31.7
25.2
+87.2%
Total assets
188
153
126
+23.0%
10-K for the year ended 31 December 2019, filed 12 March 2020: the filing.